| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.47B | +2.3% |
| Cost of Revenue | $2.67B | -1.9% |
| R&D Expense | $698.0M | +1.7% |
| SG&A Expense | $2.38B | +2.6% |
| Interest Expense | $222.0M | -1.3% |
| Pre-tax Income | $3.36B | +7.2% |
| Income Tax | $687.0M | +7.8% |
| Net Income | $2.67B | +7.5% |
| EPS (Basic) | $6.03 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.59B | +20.8% |
| Inventory | $2.43B | +5.4% |
| Current Assets | $6.77B | +13.1% |
| Total Assets | $15.47B | +8.6% |
| Current Liabilities | $2.23B | -34.5% |
| Long-term Debt | $9.04B | +73.2% |
| Total Liabilities | $12.14B | +28.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.90B | -1.7% |
| Capital Expenditures | $621.0M | -5.2% |
| Investing Cash Flow | -$748.0M | -137.5% |
| Financing Cash Flow | -$1.87B | +29.7% |
| Free Cash Flow | $2.28B | -0.7% |
| +10.2% |
| EPS (Diluted) | $6.02 | +10.1% |
| Stockholders' Equity |
| $3.33B |
| -30.2% |